Swipe om te navigeren naar een ander artikel
Cardiovascular disease (CVD) remains the leading cause of death in developed countries, despite the decline of CVD mortality over the last two decades. From observational, predictive research, efforts have been made to find causal risk factors for CVD. However, in recent years, some of these findings have been shown to be mistaken. Possible explanations for the discrepant findings are confounding and reverse causation. Genetic epidemiology has tried to address these problems through the use of Mendelian randomisation. In this paper, we discuss the promise and limitations of using genetic variation for establishing causality of cardiovascular risk factors.
Mendis S, Puska P, Norrving B, editors. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011. Available from: www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/.
Gabriel SR, Carmona L, Roque M, et al. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2005;(2):CD002229.
Gray R, Wheatley K. How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant. 1991;7 Suppl 3:9–12. PubMed
Mendel G. Experiments in plant hybridization. 1865. Available from: www.mendelweb.org/archive/Mendel.Experiments.txt.
- Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality
R. A. J. Smit
A. J. M. de Craen
J. W. Jukema
- Bohn Stafleu van Loghum